Bausch and Glenmark announce approval of RYALTRIS in Canada
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
One in two women with advanced ovarian cancer has an HRD-positive tumor
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Apollo Pharmacy has over 50% market share amongst India’s organized pharmacies
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
Subscribe To Our Newsletter & Stay Updated